Related Experiment Video
Updated: May 7, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease
B Agerholm-Larsen1, A Tybjaerg-Hansen, R Frikke-Schmidt
1Herlev University Hospital, Denmark.
The angiotensin-converting enzyme (ACE) gene polymorphism is not a significant risk factor for ischemic cerebrovascular disease. This study found no association between ACE gene variants and stroke in men or women.
Area of Science:
- Cardiovascular Genetics
- Neurology
- Molecular Epidemiology
Background:
- The deletional allele of the angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism has been proposed as a risk factor for myocardial infarction and ischemic cerebrovascular disease.
- Previous studies suggested a strong association, but findings were not consistently confirmed.
- This research investigates the ACE gene polymorphism's role in cerebrovascular disease.
Purpose of the Study:
- To determine the association between ACE gene polymorphism and the risk of ischemic cerebrovascular disease.
- To analyze this association across different study designs and in both sexes.
Main Methods:
- Employed two case-referent studies and one cross-sectional study involving a large general population sample from Copenhagen, Denmark.
- Included detailed genotypic analysis alongside assessment of conventional cardiovascular risk factors such as age, BMI, lipids, and hypertension.
- Compared individuals with and without ischemic cerebrovascular disease, including those with significant carotid stenosis.
Main Results:
- Odds ratios for ischemic cerebrovascular disease associated with ACE genotype classes were not statistically significant in any of the three studies.
- Logistic regression analysis, controlling for age and cardiovascular risk factors, also showed no significant association in either sex.
- Combined analysis of all studies further supported the lack of a significant link between ACE gene polymorphism and cerebrovascular disease.
Conclusions:
- The ACE gene polymorphism is not a statistically significant risk factor for developing ischemic cerebrovascular disease in the studied population.
- No significant differences were observed in disease development across different ACE genotype classes in men or women.
- These findings do not support a role for ACE gene polymorphism in the etiology of ischemic cerebrovascular disease.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets